// App-Quantinova.ai

: Predictors of Adverse Clinical Outcome in Diffuse Large B-Cell Lymphoma Richter Transformation of CLL/SLL: A Consortium of Richter Transformation Investigators (CORTI) Multicenter Study across 8 US, UK, and Australian Academic Centers

Researchers

Presenter

  • Emily Symes

Principal Investigators

  • Stephen K. Walker

  • Vishakha Sovani

  • Nicolas Lopez-Hisijos

  • Barina Aqil

  • Mir Alikhan

  • Claudiu V. Cotta

  • Sean Harrop

  • Angela Lager

  • Beenu Thakral

  • Peter A. Riedell

  • Carrie Fitzpatrick

  • Michael J. Thirman

  • Anand Ashwin Patel

  • Caner Saygin

  • Sandra L. Ondrejka

  • Michael R. Bishop

  • Amir Behdad

  • Sandeep Gurbuxani

  • Daniel A. Arber

  • M. James You

  • Richard A. Larson

  • Sonali M. Smith

  • Yan Amber Hodgson

  • Justin Kline

  • Matthew Ku

  • Girish Venkataraman

Medical Centers

  • Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL

  • Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH

  • Centre for Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom

  • Department of Haematology, St Vincent's Hospital Melbourne, Melbourne, Australia

  • Northwestern University Feinberg School of Medicine, Chicago, IL

  • Section of Hematology/Oncology, Department of Medicine, University of Chicago Medicine, Chicago, IL

  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL

  • Department of Histopathology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom

  • Department of Pathology, Rush University, CHICAGO, IL

  • Comprehensive Cancer Center, University of Chicago Medicine, Chicago, IL

  • Department of Pathology, NorthShore University, Evanston, IL

  • Section of Hematology/Oncology, University of Chicago, Chicago, IL

Locations

  • United States

  • United Kingdom

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Diffuse large B-cell lymphoma

Biomarkers

  • N/A

Drug/Treatment

  • Rituximab

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved